These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

564 related articles for article (PubMed ID: 25773145)

  • 1. Correlation of gene methylation in surgical margin imprints with locoregional recurrence in head and neck squamous cell carcinoma.
    Hayashi M; Wu G; Roh JL; Chang X; Li X; Ahn J; Goldsmith M; Khan Z; Bishop J; Zhang Z; Zhou XC; Richmon J; Agrawal N; Koch WM
    Cancer; 2015 Jun; 121(12):1957-65. PubMed ID: 25773145
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Innovative rapid gene methylation analysis of surgical margin tissues in head and neck cancer.
    Hayashi M; Guerrero-Preston R; Okamura J; Michailidi C; Kahn Z; Li X; Ahn J; Goldsmith M; Koch W
    Ann Surg Oncol; 2014 Sep; 21(9):3124-31. PubMed ID: 24671639
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Paired box 5 methylation detection by droplet digital PCR for ultra-sensitive deep surgical margins analysis of head and neck squamous cell carcinoma.
    Hayashi M; Guerrero-Preston R; Sidransky D; Koch WM
    Cancer Prev Res (Phila); 2015 Nov; 8(11):1017-26. PubMed ID: 26304463
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tissue imprint for molecular mapping of deep surgical margins in patients with head and neck squamous cell carcinoma.
    Roh JL; Westra WH; Califano JA; Sidransky D; Koch WM
    Head Neck; 2012 Nov; 34(11):1529-36. PubMed ID: 22223471
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intraoperative molecular margin analysis in head and neck cancer.
    Goldenberg D; Harden S; Masayesva BG; Ha P; Benoit N; Westra WH; Koch WM; Sidransky D; Califano JA
    Arch Otolaryngol Head Neck Surg; 2004 Jan; 130(1):39-44. PubMed ID: 14732766
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical significance of molecular alterations in histologically negative surgical margins of head and neck cancer patients.
    de Carvalho AC; Kowalski LP; Campos AH; Soares FA; Carvalho AL; Vettore AL
    Oral Oncol; 2012 Mar; 48(3):240-8. PubMed ID: 22104250
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular diagnosis of surgical margins and local recurrence in head and neck cancer patients: a prospective study.
    van Houten VM; Leemans CR; Kummer JA; Dijkstra J; Kuik DJ; van den Brekel MW; Snow GB; Brakenhoff RH
    Clin Cancer Res; 2004 Jun; 10(11):3614-20. PubMed ID: 15173067
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular analysis of surgical margins in head and neck squamous cell carcinoma patients.
    Nathan CO; Amirghahri N; Rice C; Abreo FW; Shi R; Stucker FJ
    Laryngoscope; 2002 Dec; 112(12):2129-40. PubMed ID: 12461330
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of the methylation profile of exfoliated cell samples from patients with head and neck squamous cell carcinoma.
    Longo AL; Rettori MM; de Carvalho AC; Kowalski LP; Carvalho AL; Vettore AL
    Head Neck; 2014 May; 36(5):631-7. PubMed ID: 23595968
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Quantitative methylation analyses of resection margins predict local recurrences and disease-specific deaths in patients with head and neck squamous cell carcinomas.
    Tan HK; Saulnier P; Auperin A; Lacroix L; Casiraghi O; Janot F; Fouret P; Temam S
    Br J Cancer; 2008 Jul; 99(2):357-63. PubMed ID: 18594522
    [TBL] [Abstract][Full Text] [Related]  

  • 11.
    Sailer V; Holmes EE; Gevensleben H; Goltz D; Dröge F; Franzen A; Dietrich J; Kristiansen G; Bootz F; Schröck A; Dietrich D
    Clin Epigenetics; 2017; 9():12. PubMed ID: 28174607
    [TBL] [Abstract][Full Text] [Related]  

  • 12. p53 mutation and locoregional treatment failure in head and neck squamous cell carcinoma.
    Koch WM; Brennan JA; Zahurak M; Goodman SN; Westra WH; Schwab D; Yoo GH; Lee DJ; Forastiere AA; Sidransky D
    J Natl Cancer Inst; 1996 Nov; 88(21):1580-6. PubMed ID: 8901856
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular staging of surgical margins in oral squamous cell carcinoma using promoter methylation of p16(INK4A), cytoglobin, E-cadherin, and TMEFF2.
    Shaw RJ; Hobkirk AJ; Nikolaidis G; Woolgar JA; Triantafyllou A; Brown JS; Liloglou T; Risk JM
    Ann Surg Oncol; 2013 Aug; 20(8):2796-802. PubMed ID: 23111707
    [TBL] [Abstract][Full Text] [Related]  

  • 14. PITX2 and PANCR DNA methylation predicts overall survival in patients with head and neck squamous cell carcinoma.
    Sailer V; Holmes EE; Gevensleben H; Goltz D; Dröge F; de Vos L; Franzen A; Schröck F; Bootz F; Kristiansen G; Schröck A; Dietrich D
    Oncotarget; 2016 Nov; 7(46):75827-75838. PubMed ID: 27716615
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Circulating Cell-Free SEPT9 DNA Methylation in Blood Is a Biomarker for Minimal Residual Disease Detection in Head and Neck Squamous Cell Carcinoma Patients.
    Dietrich D; Weider S; de Vos L; Vogt TJ; Färber M; Zarbl R; Hunecke A; Glosch AK; Gabrielpillai J; Bootz F; Bauernfeind FG; Kramer FJ; Kristiansen G; Brossart P; Strieth S; Franzen A
    Clin Chem; 2023 Sep; 69(9):1050-1061. PubMed ID: 37477541
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Analysis of genetic variants of frequently mutated genes in human papillomavirus-negative primary head and neck squamous cell carcinoma, resection margins, local recurrences and corresponding circulating cell-free DNA.
    Flach S; Kumbrink J; Walz C; Hess J; Drexler G; Belka C; Canis M; Jung A; Baumeister P
    J Oral Pathol Med; 2022 Sep; 51(8):738-746. PubMed ID: 35895622
    [TBL] [Abstract][Full Text] [Related]  

  • 17. KIF1A and EDNRB are differentially methylated in primary HNSCC and salivary rinses.
    Demokan S; Chang X; Chuang A; Mydlarz WK; Kaur J; Huang P; Khan Z; Khan T; Ostrow KL; Brait M; Hoque MO; Liegeois NJ; Sidransky D; Koch W; Califano JA
    Int J Cancer; 2010 Nov; 127(10):2351-9. PubMed ID: 20162572
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular assessment of histopathological staging in squamous-cell carcinoma of the head and neck.
    Brennan JA; Mao L; Hruban RH; Boyle JO; Eby YJ; Koch WM; Goodman SN; Sidransky D
    N Engl J Med; 1995 Feb; 332(7):429-35. PubMed ID: 7619114
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epigenetic inactivation of galanin and GALR1/2 is associated with early recurrence in head and neck cancer.
    Misawa K; Misawa Y; Kanazawa T; Mochizuki D; Imai A; Endo S; Carey TE; Mineta H
    Clin Exp Metastasis; 2016 Feb; 33(2):187-95. PubMed ID: 26572146
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular detection of minimal residual cancer in surgical margins of head and neck cancer patients.
    Graveland AP; de Maaker M; Braakhuis BJ; de Bree R; Eerenstein SE; Bloemena E; Leemans CR; Brakenhoff RH
    Cell Oncol; 2009; 31(4):317-28. PubMed ID: 19633367
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 29.